Case File
efta-efta00958976DOJ Data Set 9OtherFrom: Jeffrey Epstein [email protected]>
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00958976
Pages
2
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Jeffrey Epstein [email protected]>
To: Eileen Alexanderson
Subject: Re: FW: Draft Presentation re: Impact of Guarantees
Date: Fri, 05 Apr 2013 13:54:23 +0000
use 2 percent discount rates as well,
On Fri, Apr 5, 2013 at 8:16 AM, Eileen Alexanderson <
> wrote:
' Just got here, this was in my inbox-haven't looked yet myself
From: Fenn, Patridc [mallto
Sent: Frlda Aril 05 2013 12:30 AM
To:
'; Eileen Alexanderson;
Subject: FW: Draft Presentation re: Impact of Guarantees
Tom, Eileen and Ada,
Attached is a draft power point presentation of the tax effects to Leon of deferring or not deferring recognition of gain
on the exchange of AOG units for AGM interests attributable to his share of the $1 billion AMH debt that was
distributed to him in a prior year (referred to in the presentation as "Tufts gain"). The reference to "TRA" is to the Tax
Receivable Agreement between APO Corp and Leon (and the other founders), which provides for additional payments
to Leon upon a sale of his interest in AMH to APO Corp attributable to the tax benefits APO Corp derives from
additional amortization deductions that are generated through the purchase of Leon's AMH interest. You will notice
the assumptions on which the presentation and the tax effects are based, including a 10 percent discount rate. We are
in the process of running new models based on 8 percent (and making further revisions to the presentation). While the
8 percent versions should be available in the morning, I thought I would send you this draft so that you could start to
look over and start to get familiar with the nature of the issues and the concepts.
Brian Knudson of Ernst & Young prepared the model and will join us for our discussion at 2pm.
Look forward to seeing you.
Best regards
EFTA00958976
IRS Circular 230 Notice Requirement: This communication is not given in the form of a covered
opinion, within the meaning of Circular 230 issued by the United States Secretary of the Treasury.
Thus, we are required to inform you that you cannot rely upon any tax advice contained in this
communication for the purpose of avoiding United States federal tax penalties. In addition, any
tax advice contained in this communication may not be used to promote, market or recommend a
transaction to another party.
The information contained in this e-mail message is intended only for the personal and
confidential use of the recipient(s) named above. If you have received this communication in
error, please notify us immediately by e-mail, and delete the original message.
This email and any files transmitted with it are confidential
and intended solely for the person or entity to whom they are
addressed and may contain confidential and/or privileged
material. Any review, retransmission, dissemination or
other use of, or taking of any action in reliance upon this
information by persons or entities other than the intended
recipient is prohibited. If you have received this email in
error please contact the sender and delete the material from
any computer.
Apollo Global Management, LLC
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00958977
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.